Neogen Corporation Tax Withholding Paid on Stock Awards
Neogen Corporation (NEOG) reported Tax Withholding Paid on Stock Awards of $900.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-30
- Neogen Corporation payment, tax withholding, share-based payment arrangement for the quarter ending 2026-05-31 was $200.00K.
- Neogen Corporation payment, tax withholding, share-based payment arrangement for the quarter ending 2026-02-28 was $53.00K, a 13.11% decline year-over-year.
- Neogen Corporation payment, tax withholding, share-based payment arrangement for the quarter ending 2025-11-30 was $424.00K, a 70.54% decline year-over-year.
- Neogen Corporation payment, tax withholding, share-based payment arrangement for the quarter ending 2025-08-31 was $223.00K.
- Neogen Corporation payment, tax withholding, share-based payment arrangement for fiscal 2026 was $900.00K, a 40.00% decline from fiscal 2025.
- Neogen Corporation payment, tax withholding, share-based payment arrangement for fiscal 2025 was $1.50M, a 1400.00% increase from fiscal 2024.
- Neogen Corporation payment, tax withholding, share-based payment arrangement for fiscal 2024 was $100.00K.
- Neogen Corporation payment, tax withholding, share-based payment arrangement for fiscal 2023 was $0.00.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 12 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-05-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $253.00K derived: sum of 2 quarters · filed 2026-07-30 | $677.00K derived: sum of 3 quarters · filed 2026-07-30 | $900.00K 10-K · filed 2026-07-30 | ||
| 2026-02-28 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | $477.00K derived: sum of 2 quarters · filed 2026-04-09 | $700.00K 10-Q · filed 2026-04-09 | $700.00K derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-11-30 | $424.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $647.00K 10-Q · filed 2026-01-08 | $647.00K derived: sum of 3 quarters · filed 2026-07-30 | $708.00K derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-08-31 | $223.00K 10-Q · filed 2025-10-09 | $223.00K derived: sum of 2 quarters · filed 2026-07-30 | $284.00K derived: sum of 3 quarters · filed 2026-07-30 | $1.72M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $61.00K derived: sum of 2 quarters · filed 2026-07-30 | $1.50M derived: sum of 3 quarters · filed 2026-07-30 | $1.50M 10-K · filed 2026-07-30 | ||
| 2025-02-28 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | $1.50M derived: sum of 2 quarters · filed 2026-04-09 | $1.50M 10-Q · filed 2026-04-09 | $1.48M 10-Q · filed 2025-04-09 | $1.50M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2024-11-30 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $1.44M 10-Q · filed 2026-01-08 | $1.44M derived: sum of 3 quarters · filed 2026-07-30 | $1.45M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-08-31 | $0.00 10-Q · filed 2025-10-09 | $4.00K derived: sum of 2 quarters · filed 2026-07-30 | $11.00K derived: sum of 3 quarters · filed 2026-07-30 | |||
| 2024-05-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $11.00K derived: sum of 2 quarters · filed 2026-07-30 | $100.00K 10-K · filed 2026-07-30 | $118.00K 10-K · filed 2025-07-30 | ||
| 2024-02-29 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-09 | $96.00K 10-Q · filed 2025-04-09 | ||||
| 2023-11-30 | $89.00K 10-Q · filed 2025-01-15 | |||||
| 2023-05-31 | $0.00 10-K · filed 2025-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |